Skip to content

Technology Listing:

Biomarker for Low Risk NTM Infection in the Airway of Cystic Fibrosis Patients - 20-03

Biomarkers to Differentiate Atopic Dermatitis Endotypes - 19-01

Biomarkers Predictive of Atopic Dermatitis Susceptibility - 17-06

TSLP: A Biomarker Predictive of Atopic Dermatitis Development in Infants - 16-06

Gene panel diagnostic test predictive of ARDS severity - 15-04

TAK-1 and MSK-1: biomarkers and targets for corticosteroid-resistant asthma - 13-12

Blood Biomarkers Determine Therapeutic Response in Cystic Fibrosis Patients - 08-22

Adenosine A2A Receptor: A Prognosis Marker for Lung Cancer - 08-11

MAGP-2: An extracellular factor shown to have pro-angiogenic properties - 06-05 

New Agar Medium for the Isolation and Testing Susceptibility of Mycobacterium Tuberculosis Against Drugs - 00-05



View list of available Therapeutics.

Research Tools

View list of available Antibodies or Animal models.


Biomedical Devices

View list of available biomedical devices.


For more information, contact Emmanuel Hilaire at